PharmaDispatch - BioPharmaDispatch

Latest News
Is this what health technology assessment has become in Australia?

Increased costs from earlier treatment and other interventions are a natural consequence of screening more rapid diagnosis. They are the reason for screening and not the reason not to.

TGA authorises government campaign promoting COVID-19 treatments July 4, 2022
The TGA has laid the groundwork for the federal government's $11 million campaign by authorising its promotion of antiviral treatments for COVID-19.
Latest News Australian researchers identify new drug target for inflammatory lung disease July 5, 2022
Australian researchers have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease.
Latest News Pre-Budget spending rules not quite that strict after all July 4, 2022
The diabetes decision and potentially Friday's confirmation of 1 July PBS listings suggest some election commitments have been prioritised over others and that the claimed strict spending rules are not that strict after all.
Latest News The health system review that is not even being led by health July 4, 2022
Do history and the experience of previous ministers suggest this review might reflect the desire of central agencies to gain control of health policy?
Latest News Few should expect 'ministerial discretion' and few should actually apply July 4, 2022
The federal parliament endorsed the enabling legislation last year with no debate or real scrutiny despite public recognition of 'unintended consequences' in the form of undesirable delistings of PBS-listed medicines.
Lung cancer screening would save lives but too expensive July 3, 2022
The committee did not recommend even a limited and narrowly targeted screening program despite saying it would reduce deaths from lung cancer.
Latest News Novartis considers spin-out of Sandoz off-patent division July 4, 2022
The company has previously announced a strategic review of the division that currently generates around US$10 billion in annual revenue.
Latest News Over 1,000 medicines facing 'catch-up' reductions in April July 1, 2022
Companies will be closely examining the just published the list of over 1,000 PBS-listed medicines that will be the subject of catch-up price reductions on 1 April next year.
Latest News The 'Halton review' likely to be the first of many on pandemic performance July 1, 2022
There are obvious implications from health minister Mark Butler's decision to order a review into Australia's current COVID-19 vaccine and therapeutic procurement arrangements.
Latest News Bayer secures new PBS listing and Medicare funded diagnostic July 1, 2022
Australian children now have reimbursed access to a medicine and matching genetic test that enables the underlying cause of multiple NTRK gene fusion cancers to be treated.
BeiGene welcomes expanded listing for targeted blood cancer therapy June 30, 2022
BeiGene has welcomed the expanded PBS listing of its targeted therapy BRUKINSA (zanubritinib) for the treatment of Waldenstrom Macroglobulinemia.
Latest News AbbVie delivers in its annual 'Month of Possibilities' volunteering event July 1, 2022
After a two-year pandemic-driven hiatus AbbVie has completed its 'Month of Possibilities' annual volunteering event that saw over 170 employees participate in community-focused activities.
Latest News Out with the old industry agreements, and in with the new June 30, 2022
It is the last day of the federal government's current five agreements with Medicines Australia and the Generic and Biosimilar Medicines Association.
Latest News Industry says 'perpetuity' requirement will undermine early access fund June 30, 2022
The research-based pharmaceutical industry has raised concerns over the viability of the UK's recently announced Innovative Medicines Fund.
Latest News Digital clinical trial recruitment platform in new agreements with patient groups June 30, 2022
The agreements with Neuroendocrine Cancer Australia and Pancare Foundation aim to facilitate the rapid recruitment of patients in new trials via Opyl's Opin digital platform.
Latest News Election commitment could be lost to October Budget process June 28, 2022
Mr Butler won significant praise for his commitment, including from the several hundred people who attended the conference, but could it be lost to the Budget's operational rules?
Latest News Is the Budget process intended to undermine election commitments? June 29, 2022
Does the government seriously believe a not-for-profit organisation can wind down its operation, effectively go into hibernation while it goes through its Budget process, and then re-emerge as if nothing happened?
Latest News Mark Butler says reform of newborn screening is happening June 28, 2022
Health minister Mark Butler has used International Neonatal Screening Day to reassert the federal government's commitment to a significant expansion of Australia's newborn screening program.

News of the Day

Australian Biotech

Other Health

Latest Video

Most Read

New Stories